Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,819 across all filing types
Latest filing 2022-08-01 Transaction in Own Shar…
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
Transactions in connection with share buy-back program
Transaction in Own Shares Classification · 100% confidence The document is a company announcement detailing specific transactions executed under a share buy-back program. It provides a table of daily share repurchases, total values, and the impact on treasury shares. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers reports of companies buying back their own shares.
2022-08-01 Danish
6-K
Foreign Filer Report
2022-07-25 English
Transaction in Own Shares 2022
Transaction in Own Shares Classification · 100% confidence The document is titled "Transactions in connection with share buy-back program" and details the number of shares bought back by the company (Genmab A/S) between specific dates (July 18, 2022, to July 22, 2022). This activity directly relates to the company managing its own stock, which falls under the definition of 'Transaction in Own Shares'. The document explicitly reports the execution of transactions under a previously announced share buy-back program. This matches the definition for Code: POS.
2022-07-25 English
Transactions in connection with share buy-back program
Transaction in Own Shares Classification · 100% confidence The document is a detailed appendix listing individual share buyback transactions (volume, price, venue, and timestamp) for Genmab over a specific period (July 18-22, 2022). This type of disclosure is a standard regulatory requirement for companies executing share repurchase programs to provide transparency on their own share transactions. According to the provided definitions, 'Transaction in Own Shares' (POS) is the correct category for reports detailing the company buying back its own shares.
2022-07-25 English
Transactions in connection with share buy-back program
Transaction in Own Shares Classification · 100% confidence The document is a formal company announcement detailing specific transactions executed under a share buy-back program. It provides a table of daily share repurchases, the total number of shares bought, and the impact on treasury shares. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2022-07-25 English
6-K
Foreign Filer Report
2022-07-20 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.